Genetically engineered cellular nanoparticles loaded with curcuminoids for cancer immunotherapy

Inducing immunogenic cell death (ICD) is a promising strategy to enhance immune responses for immune checkpoint blockade (ICB) therapy, but the lack of a simple and effective platform to integrate ICD and ICB therapy limits their clinical application.